The skin and soft tissue infections in hematological patients.

Riccardo Ungaro, Malgorzata Mikulska
Author Information
  1. Riccardo Ungaro: Division of Infectious Diseases, Department of Health Sciences DISSAL, University of Genoa.
  2. Malgorzata Mikulska: Division of Infectious Diseases, Department of Health Sciences DISSAL, University of Genoa.

Abstract

PURPOSE OF REVIEW: Skin and soft tissue infections (SSTIs) in patients with hematological malignancies are frequent, but dedicated epidemiological studies are limited. The aim of this review is to provide updated description of the main etiological agents, differential diagnosis, and treatment.
RECENT FINDINGS: In addition to common causes of bacterial skin infections in any kind of patients, such as streptococci and staphylococci (the letter frequently resistant to methicillin), Pseudomonas aeruginosa is a frequent agent in patients with hematological malignancies, with high virulence and typical infection presenting as ecthyma gangrenosum. Among fungi, fusariosis is the mold infection most frequently associated with skin lesions, although other molds and yeasts (including Candida tropicalis) should be also considered. External infections associated with central venous catheters are frequent in the hematological setting, and in addition to staphylococci, Gram-negative bacteria, fungi, and even rapid growing nontuberculous mycobacteria should be considered. Immunodeficiency might either blunt the typical inflammatory response and make sign or symptoms less evident, or predispose the patients to rapid progression of skin infection to subcutaneous tissues or dissemination.
SUMMARY: SSTIs in hematology patients can be caused by various infectious agents resulting in similar clinical presentation. Rapid and accurate diagnosis is fundamental in order to reduce morbidity and mortality.

References

  1. Clin Cosmet Investig Dermatol. 2019 May 30;12:373-381 [PMID: 31239742]
  2. Hematol Oncol Clin North Am. 2017 Dec;31(6):981-993 [PMID: 29078933]
  3. J Infect Chemother. 2017 Apr;23(4):250-252 [PMID: 27847295]
  4. J Chemother. 2017 Aug;29(4):197-214 [PMID: 28378613]
  5. Clin Microbiol Infect. 2014 Jun;20(6):580-5 [PMID: 24118322]
  6. Medicine (Baltimore). 2018 Oct;97(40):e12436 [PMID: 30290600]
  7. J Clin Microbiol. 2018 May 25;56(6): [PMID: 29563199]
  8. Eur Respir J. 2013 Dec;42(6):1604-13 [PMID: 23598956]
  9. Clin Transplant. 2019 Sep;33(9):e13588 [PMID: 31077618]
  10. J Med Case Rep. 2015 Jan 19;9:9 [PMID: 25597932]
  11. World J Oncol. 2018 Apr;9(2):62-65 [PMID: 29760835]
  12. Medicine (Baltimore). 2015 Jul;94(26):e1018 [PMID: 26131805]
  13. J Cutan Pathol. 2017 May;44(5):433-443 [PMID: 28098393]
  14. Blood Rev. 2017 Nov;31(6):370-388 [PMID: 28732587]
  15. Clin Microbiol Rev. 2015 Apr;28(2):313-35 [PMID: 25762531]
  16. Curr Opin Infect Dis. 2017 Aug;30(4):354-363 [PMID: 28542092]
  17. Am J Infect Control. 2020 Jan;48(1):40-45 [PMID: 31395288]
  18. Transpl Infect Dis. 2019 Oct;21(5):e13147 [PMID: 31306546]
  19. Intern Med. 2018 Feb 1;57(3):423-427 [PMID: 29093379]
  20. Biol Blood Marrow Transplant. 2018 Sep;24(9):1783-1787 [PMID: 29653205]
  21. Biol Blood Marrow Transplant. 2018 Feb;24(2):366-372 [PMID: 28986190]
  22. JAAD Case Rep. 2019 Jan 28;5(2):162-166 [PMID: 30733986]
  23. Br J Haematol. 2011 Nov;155(3):286 [PMID: 21679167]
  24. Clin Microbiol Infect. 2018 Oct;24(10):1105.e1-1105.e4 [PMID: 29787890]
  25. J Vasc Access. 2018 May;19(3):230-242 [PMID: 29512430]
  26. An Bras Dermatol. 2018 Sep-Oct;93(5):726-729 [PMID: 30156626]
  27. J Cutan Pathol. 2019 Feb;46(2):159-161 [PMID: 30468020]
  28. SAGE Open Med Case Rep. 2019 Mar 01;7:2050313X19834425 [PMID: 30854206]
  29. Mayo Clin Proc. 2012 Oct;87(10):1004-14 [PMID: 22819486]
  30. Bone Marrow Transplant. 2018 Jan;53(1):78-83 [PMID: 29035398]
  31. Bone Marrow Transplant. 2020 Jan;55(1):110-116 [PMID: 31435035]
  32. Transpl Infect Dis. 2019 Apr;21(2):e13039 [PMID: 30548761]
  33. Clin Microbiol Infect. 2018 Mar;24(3):246-250 [PMID: 28847765]
  34. Acta Derm Venereol. 2019 Sep 1;99(10):889-893 [PMID: 31141157]
  35. Clin Infect Dis. 2010 Aug 15;51(4):422-34 [PMID: 20617902]
  36. Eur J Clin Microbiol Infect Dis. 2015 Apr;34(4):633-9 [PMID: 25407372]
  37. Semin Oncol. 2016 Jun;43(3):359-65 [PMID: 27178689]
  38. Ann Hematol. 2015 Sep;94(9):1441-50 [PMID: 26193852]
  39. Int J Dermatol. 2019 Apr;58(4):E83-E85 [PMID: 30548464]
  40. Curr Opin Infect Dis. 2017 Dec;30(6):545-551 [PMID: 28922286]
  41. Acta Haematol. 2018;139(1):19-27 [PMID: 29320771]
  42. BMC Infect Dis. 2018 Apr 10;18(1):163 [PMID: 29631541]
  43. Nat Rev Dis Primers. 2019 Jan 31;5(1):9 [PMID: 30705286]
  44. Microbiol Spectr. 2016 Aug;4(4): [PMID: 27726817]
  45. J Infect. 2014 Apr;68(4):321-31 [PMID: 24370562]
  46. Clin Infect Dis. 2020 Jul 27;71(3):556-563 [PMID: 31504341]
  47. Acta Haematol. 2017;138(1):10-13 [PMID: 28586772]
  48. J Hosp Infect. 2005 Sep;61(1):53-61 [PMID: 16002181]
  49. Medicine (Baltimore). 2019 Jun;98(26):e16246 [PMID: 31261588]
  50. Transpl Infect Dis. 2017 Feb;19(1): [PMID: 27775824]
  51. Infect Control Hosp Epidemiol. 2015 Jan;36(1):76-80 [PMID: 25627764]
  52. Clin Infect Dis. 2009 Jul 1;49(1):1-45 [PMID: 19489710]
  53. Cureus. 2018 Apr 6;10(4):e2441 [PMID: 29881654]
  54. Transpl Infect Dis. 2016 Dec;18(6):942-945 [PMID: 27696601]
  55. World J Surg Oncol. 2016 Apr 19;14:116 [PMID: 27094880]
  56. Lancet Infect Dis. 2016 Nov;16(11):e241-e250 [PMID: 27788992]
  57. J Med Case Rep. 2014 Sep 22;8:315 [PMID: 25245365]
  58. Intern Med. 2019 Mar 15;58(6):877-882 [PMID: 30449799]
  59. J Eur Acad Dermatol Venereol. 2015 Sep;29(9):1837-9 [PMID: 25186152]
  60. Curr Med Mycol. 2019 Mar;5(1):27-31 [PMID: 31049455]
  61. Clin Infect Dis. 2016 Aug 1;63(3):338-45 [PMID: 27090987]
  62. Int J Dermatol. 2010 Dec;49(12):1380-5 [PMID: 21155087]
  63. Open Forum Infect Dis. 2018 Jul 18;5(7):ofy168 [PMID: 30090839]
  64. IDCases. 2019 May 31;17:e00566 [PMID: 31194156]
  65. Case Rep Dermatol. 2019 Feb 26;11(1):52-56 [PMID: 31043940]
  66. Front Oncol. 2014 Nov 10;4:311 [PMID: 25426446]
  67. J Clin Med. 2019 Feb 07;8(2): [PMID: 30736487]
  68. An Bras Dermatol. 2017 May-Jun;92(3):304-311 [PMID: 29186239]
  69. Mycoses. 2019 Sep;62(9):826-834 [PMID: 31069853]
  70. Eur J Gastroenterol Hepatol. 2018 Jul;30(7):722-726 [PMID: 29659377]
  71. J Clin Diagn Res. 2016 Jul;10(7):DC24-8 [PMID: 27630843]
  72. Case Rep Crit Care. 2018 Apr 01;2018:1475730 [PMID: 29805813]
  73. Lancet Infect Dis. 2019 Jun;19(6):e200-e212 [PMID: 30744963]
  74. Thorax. 2017 Nov;72(Suppl 2):ii1-ii64 [PMID: 29054853]
  75. Clin Microbiol Rev. 2016 Jan;29(1):191-9 [PMID: 26656674]
  76. Int J Infect Dis. 2008 Mar;12(2):120-5 [PMID: 17723316]

MeSH Term

Hematologic Diseases
Humans
Risk Factors
Skin Diseases, Bacterial
Soft Tissue Infections

Word Cloud

Created with Highcharts 10.0.0patientsinfectionshematologicalskinfrequentinfectionsofttissueSSTIsmalignanciesagentsdiagnosisadditionstaphylococcifrequentlytypicalfungiassociatedconsideredrapidPURPOSEOFREVIEW:SkindedicatedepidemiologicalstudieslimitedaimreviewprovideupdateddescriptionmainetiologicaldifferentialtreatmentRECENTFINDINGS:commoncausesbacterialkindstreptococciletterresistantmethicillinPseudomonasaeruginosaagenthighvirulencepresentingecthymagangrenosumAmongfusariosismoldlesionsalthoughmoldsyeastsincludingCandidatropicalisalsoExternalcentralvenouscatheterssettingGram-negativebacteriaevengrowingnontuberculousmycobacteriaImmunodeficiencymighteitherbluntinflammatoryresponsemakesignsymptomslessevidentpredisposeprogressionsubcutaneoustissuesdisseminationSUMMARY:hematologycancausedvariousinfectiousresultingsimilarclinicalpresentationRapidaccuratefundamentalorderreducemorbiditymortality

Similar Articles

Cited By